Khiron Life Sciences Corp. a vertically integrated cannabis company with core operations in Latin America has entered into an agreement with Tecnologico de Monterrey in Mexico bringing science-based online medical cannabis education to an initial group of up to 1,500 healthcare practitioners. With costs covered by Khiron, the program launches the Company’s Latin America medical cannabis education strategy, positioning Khiron as a leader in increasing the understanding and application of cannabinoid therapies in the region.
“In the new reality of Covid-19, the development of online continuing medical education programs with highly scientific content is critical to fulfill current gaps and support needed in medical cannabis academic training among healthcare practitioners. Our doctor education strategy, and relationship with Tecnologico de Monterrey in Mexico, encourages our person-centred care, and contributes to our commitment to medical cannabis education and responsible prescription of cannabinoid therapy,” comments Rodrigo Duran, Khiron VP Pharma.
Tecnologico de Monterrey medical cannabis program begins with online based courses in Q2 2020, introducing healthcare providers across Latin America to specific regulatory frameworks, clinical evidence and research, safety considerations, clinical cases and practical recommendations to best meet current patient needs. A second phase will launch in Q3 2020.
“As the leading university in Mexico we have a responsibility to bring the highest level of education to our physician population including different specialities of physicians. In the emerging field of medical cannabis, the partnership with Khiron Life Sciences means we can do this in an informed, science-based environment that will raise knowledge among Latin American healthcare professionals and prepare them to bring greater treatment options to patients,” comments Gabriela Villarreal Levy MD, MPH, Associate Dean of Continuing Medical Education at Tecnologico de Monterrey.
“This partnership continues Khirons innovation model in reaching doctors and patients virtually, including our recently announced teleconsultation service which allows patients, including those in our ILANS and Zerenia clinics to access clinic services and doctors trained to prescribe medical cannabis,” comments Alvaro Torres, Khiron CEO and director.